BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

245 related articles for article (PubMed ID: 15085203)

  • 1. A preoperative diagnostic test that distinguishes benign from malignant thyroid carcinoma based on gene expression.
    Cerutti JM; Delcelo R; Amadei MJ; Nakabashi C; Maciel RM; Peterson B; Shoemaker J; Riggins GJ
    J Clin Invest; 2004 Apr; 113(8):1234-42. PubMed ID: 15085203
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Diagnosis of suspicious thyroid nodules using four protein biomarkers.
    Cerutti JM; Latini FR; Nakabashi C; Delcelo R; Andrade VP; Amadei MJ; Maciel RM; Hojaij FC; Hollis D; Shoemaker J; Riggins GJ
    Clin Cancer Res; 2006 Jun; 12(11 Pt 1):3311-8. PubMed ID: 16740752
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The new molecular markers DDIT3, STT3A, ARG2 and FAM129A are not useful in diagnosing thyroid follicular tumors.
    Sigstad E; Paus E; Bjøro T; Berner A; Grøholt KK; Jørgensen LH; Sobrinho-Simões M; Holm R; Warren DJ
    Mod Pathol; 2012 Apr; 25(4):537-47. PubMed ID: 22157935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Differentiation of follicular thyroid adenoma from carcinoma by means of gene expression profiling with adapter-tagged competitive polymerase chain reaction.
    Taniguchi K; Takano T; Miyauchi A; Koizumi K; Ito Y; Takamura Y; Ishitobi M; Miyoshi Y; Taguchi T; Tamaki Y; Kato K; Noguchi S
    Oncology; 2005; 69(5):428-35. PubMed ID: 16319515
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of GPER1, EGFR and CXCR1 in differentiating between malignant follicular thyroid carcinoma and benign follicular thyroid adenoma.
    Zhao L; Zhu XY; Jiang R; Xu M; Wang N; Chen GG; Liu ZM
    Int J Clin Exp Pathol; 2015; 8(9):11236-47. PubMed ID: 26617848
    [TBL] [Abstract][Full Text] [Related]  

  • 6. STT3A, C1orf24, TFF3: putative markers for characterization of follicular thyroid neoplasms from fine-needle aspirates.
    Patel MR; Stadler ME; Deal AM; Kim HS; Shores CG; Zanation AM
    Laryngoscope; 2011 May; 121(5):983-9. PubMed ID: 21520112
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Overexpression of mir-129-1, miR-146b, mir-183, and mir-197 in follicular thyroid carcinoma and adenoma tissues.
    Sheikholeslami S; Shabani N; Shivaee S; Tavangar SM; Yeganeh M; Hedayati M; Lotfi J; Gholami H
    Mol Cell Probes; 2020 Jun; 51():101536. PubMed ID: 32081771
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Network-Based Genetic Profiling Reveals Cellular Pathway Differences Between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma.
    Hossain MA; Asa TA; Rahman MM; Uddin S; Moustafa AA; Quinn JMW; Moni MA
    Int J Environ Res Public Health; 2020 Feb; 17(4):. PubMed ID: 32093341
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Gene Expression (mRNA) Markers for Differentiating between Malignant and Benign Follicular Thyroid Tumours.
    Wojtas B; Pfeifer A; Oczko-Wojciechowska M; Krajewska J; Czarniecka A; Kukulska A; Eszlinger M; Musholt T; Stokowy T; Swierniak M; Stobiecka E; Chmielik E; Rusinek D; Tyszkiewicz T; Halczok M; Hauptmann S; Lange D; Jarzab M; Paschke R; Jarzab B
    Int J Mol Sci; 2017 Jun; 18(6):. PubMed ID: 28574441
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Expression of GADD153 in follicular tumors of thyroid and comparison with CK19, Galectin-3 and HBME-1].
    Tang QS; Teng XD; Ding W; Zhou J; Yao HT; Ying LX; Xu LM
    Zhonghua Bing Li Xue Za Zhi; 2011 Nov; 40(11):745-8. PubMed ID: 22336157
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of matrix metalloproteinase-2, but not caspase-3, facilitates distinction between benign and malignant thyroid follicular neoplasms.
    Sanii S; Saffar H; Tabriz HM; Qorbani M; Haghpanah V; Tavangar SM
    Asian Pac J Cancer Prev; 2012; 13(5):2175-8. PubMed ID: 22901190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Genetic classification of benign and malignant thyroid follicular neoplasia based on a three-gene combination.
    Weber F; Shen L; Aldred MA; Morrison CD; Frilling A; Saji M; Schuppert F; Broelsch CE; Ringel MD; Eng C
    J Clin Endocrinol Metab; 2005 May; 90(5):2512-21. PubMed ID: 15713710
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of PAX8-PPAR gamma 1 rearrangements in both follicular thyroid carcinomas and adenomas.
    Marques AR; Espadinha C; Catarino AL; Moniz S; Pereira T; Sobrinho LG; Leite V
    J Clin Endocrinol Metab; 2002 Aug; 87(8):3947-52. PubMed ID: 12161538
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Nodule diagnosed as follicular patterned lesion: are biomarkers the promise?].
    Cerutti JM
    Arq Bras Endocrinol Metabol; 2007 Jul; 51(5):832-42. PubMed ID: 17891248
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mutational burdens and evolutionary ages of thyroid follicular adenoma are comparable to those of follicular carcinoma.
    Jung SH; Kim MS; Jung CK; Park HC; Kim SY; Liu J; Bae JS; Lee SH; Kim TM; Lee SH; Chung YJ
    Oncotarget; 2016 Oct; 7(43):69638-69648. PubMed ID: 27626165
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Differences in Mutational Profile between Follicular Thyroid Carcinoma and Follicular Thyroid Adenoma Identified Using Next Generation Sequencing.
    Borowczyk M; Szczepanek-Parulska E; Dębicki S; Budny B; Verburg FA; Filipowicz D; Więckowska B; Janicka-Jedyńska M; Gil L; Ziemnicka K; Ruchała M
    Int J Mol Sci; 2019 Jun; 20(13):. PubMed ID: 31248021
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Two-miRNA classifiers differentiate mutation-negative follicular thyroid carcinomas and follicular thyroid adenomas in fine needle aspirations with high specificity.
    Stokowy T; Wojtas B; Jarzab B; Krohn K; Fredman D; Dralle H; Musholt T; Hauptmann S; Lange D; Hegedüs L; Paschke R; Eszlinger M
    Endocrine; 2016 Nov; 54(2):440-447. PubMed ID: 27473101
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Molecular differential diagnosis of follicular thyroid carcinoma and adenoma based on gene expression profiling by using formalin-fixed paraffin-embedded tissues.
    Pfeifer A; Wojtas B; Oczko-Wojciechowska M; Kukulska A; Czarniecka A; Eszlinger M; Musholt T; Stokowy T; Swierniak M; Stobiecka E; Rusinek D; Tyszkiewicz T; Kowal M; Jarzab M; Hauptmann S; Lange D; Paschke R; Jarzab B
    BMC Med Genomics; 2013 Oct; 6():38. PubMed ID: 24099521
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biological differential diagnosis of follicular thyroid tumor and Hürthle cell tumor on the basis of telomere length and hTERT expression.
    Sugishita Y; Kammori M; Yamada O; Yamazaki K; Ito K; Fukumori T; Yoshikawa K; Yamada T
    Ann Surg Oncol; 2014 Jul; 21(7):2318-25. PubMed ID: 24562933
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High Ki-67 index in fine needle aspiration cytology of follicular thyroid tumors is associated with increased risk of carcinoma.
    Mu N; Juhlin CC; Tani E; Sofiadis A; Reihnér E; Zedenius J; Larsson C; Nilsson IL
    Endocrine; 2018 Aug; 61(2):293-302. PubMed ID: 29796987
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.